Moleculin Biotech Inc (NASDAQ:MBRX)

3.37
Delayed Data
As of May 06
 -0.11 / -3.13%
Today’s Change
3.12
Today|||52-Week Range
9.30
-29.54%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Moleculin Biotech Inc have a median target of 18.00, with a high estimate of 29.00 and a low estimate of 14.00. The median estimate represents a +434.12% increase from the last price of 3.37.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Moleculin Biotech Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.23
Sales
$0.00
Reporting Date
May 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.17%
 
 
 
 
 
 
Growthannually 52.46%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.